Scholar Rock Holding Corp
For the period ended Dec 31, 2025. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 3, 2026
SRRK$48.00-6.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
(In thousands, except share data)
| | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · Accumulated · · · · · | |||||||||||||||||
| · · · · · · · Additional · · Other · · · · · Total | |||||||||||||||||
| · · Common Stock · · Paid‑in · · Comprehensive · · Accumulated · · Stockholders’ | |||||||||||||||||
| · · Shares · · Amount · · Capital · · Income (Loss) · · Deficit · · Equity | |||||||||||||||||
| Balance at December 31, 2023 | | 75,979,495 | | $76 | | $901,471 | | $92 | | $(676,421) | | $225,218 | |||||
| Unrealized gain on marketable securities | | — | | | — | | | — | | | 68 | | | — | | | 68 |
| Sale of common shares and pre-funded warrants to purchase common shares, net | | 11,858,408 | | | 12 | | | 324,402 | | | — | | | — | | | 324,414 |
| Exercise of stock options | | 1,469,756 | | | 1 | | | 18,974 | | | — | | | — | | | 18,975 |
| Issuance of common shares upon RSU vesting | | 679,694 | | | 1 | | | (1) | | | — | | | — | | | — |
| Exercise of pre-funded and common warrants | | 3,836,325 | | | 4 | | | 9,621 | | | — | | | — | | | 9,625 |
| Equity-based compensation expense | | — | | | — | | | 36,628 | | | — | | | — | | | 36,628 |
| Net loss | | — | | | — | | | — | | | — | | | (246,294) | | | (246,294) |
| Balance at December 31, 2024 | | 93,823,678 | | $94 | | $1,291,095 | | $160 | | $(922,715) | | $368,634 | |||||
| Unrealized loss on marketable securities | | — | | | — | | | — | | | (64) | | | — | | | (64) |
| Sale of common shares, net of issuance costs | | 2,767,000 | | | 3 | | | 91,657 | | | — | | | — | | | 91,660 |
| Exercise of stock options | | 1,860,105 | | | 1 | | | 23,810 | | | — | | | — | | | 23,811 |
| Issuance of common shares upon RSU vesting | | 1,331,907 | | | 1 | | | (1) | | | — | | | — | | | — |
| Exercise of pre-funded and common warrants | | 8,678,664 | | | 9 | | | 63,779 | | | — | | | — | | | 63,788 |
| Equity-based compensation expense | | — | | | — | | | 75,600 | | | — | | | — | | | 75,600 |
| Foreign currency translation adjustments | | — | | | — | | | — | | | (2) | | | — | | | (2) |
| Net loss | | — | | | — | | | — | | | — | | | (377,939) | | | (377,939) |
| Balance at December 31, 2025 | | 108,461,354 | | $108 | | $1,545,940 | | $94 | | $(1,300,654) | | $245,488 | |||||
The accompanying notes are an integral part of these consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.